Lindbrook Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $10.3K | Buy |
31
+5
| +19% | +$1.66K | ﹤0.01% | 1641 |
|
|
2024
Q4 | $8.02K | Buy |
26
+8
| +44% | +$2.47K | ﹤0.01% | 1769 |
|
|
2024
Q3 | $3.82K | Sell |
18
-13
| -42% | -$2.76K | ﹤0.01% | 2127 |
|
|
2024
Q2 | $8.69K | Buy |
31
+21
| +210% | +$5.88K | ﹤0.01% | 1704 |
|
|
2024
Q1 | $2.67K | Sell |
10
-15
| -60% | -$4.01K | ﹤0.01% | 2142 |
|
|
2023
Q4 | $5.79K | Buy |
25
+22
| +733% | +$5.09K | ﹤0.01% | 1812 |
|
|
2023
Q3 | $438 | Buy |
+3
| New | +$438 | ﹤0.01% | 2562 |
|
|
2023
Q1 | – | Sell |
-25
| Closed | -$7.26K | – | 2873 |
|
|
2022
Q4 | $7.26K | Buy |
25
+12
| +92% | +$3.48K | ﹤0.01% | 1596 |
|
|
2022
Q3 | $1K | Sell |
13
-9
| -41% | -$692 | ﹤0.01% | 2402 |
|
|
2022
Q2 | $2K | Sell |
22
-17
| -44% | -$1.55K | ﹤0.01% | 1992 |
|
|
2022
Q1 | $4K | Buy |
+39
| New | +$4K | ﹤0.01% | 1714 |
|
|
2021
Q2 | – | Sell |
-4
| Closed | – | – | 1967 |
|
|
2021
Q1 | $0 | Buy |
+4
| New | – | ﹤0.01% | 1910 |
|